Thumbnail Image
Item

Author Correction: Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells

Buzzetti, M.
; 
Morlando, S.
; 
Solomos, D.
; 
Mehmood, A.
; 
Cox, A. W. I.
; 
Chiesa, M.
; 
D'Alessandra, Y.
; 
Garofalo, M.
; 
Topham, C. H.
; 
Di Leva, G.
Citations
Google Scholar:
Lookup
Altmetric:
Abstract
Authors
Buzzetti, M.
Morlando, S.
Solomos, D.
Mehmood, A.
Cox, A. W. I.
Chiesa, M.
D'Alessandra, Y.
Garofalo, M.
Topham, C. H.
Di Leva, G.
Affiliation
School of Science, Engineering and Environment, Biomedical Research Centre, Salford, Greater Manchester, UK. Transcriptional Networks in Lung Cancer Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK. Cancer Research UK Lung Cancer Centre of Excellence, at Manchester and University College London, London, UK. Bioinformatics and Artificial Intelligence Facility, Centro Cardiologico Monzino IRCCS, Milan, Italy. Immunology and Functional Genomics Unit, Centro Cardiologico Monzino IRCCS, Milan, Italy. School of Pharmacy and Bioengineering, Guy Hilton Research Centre, Keele University, Stoke-on-Trent, UK. g.dileva@keele.ac.uk.
Description
Date
2025
Publisher
Collections
All Paterson Institute for Cancer Research
Show all metadata
Files
Thumbnail Image
Found in UnPaywall
Adobe PDF, 1.03 MB
Keywords
Type
Other
Citation
Buzzetti M, Morlando S, Solomos D, Mehmood A, Cox AWI, Chiesa M, et al. Author Correction: Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells. Scientific reports. 2025 Feb 5;15(1):4384. PubMed PMID: 39910110. Pubmed Central PMCID: PMC11799310. Epub 2025/02/06. eng.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627533
Embedded videos